Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001753926-25-001827
Filing Date
2025-11-25
Accepted
2025-11-25 08:30:42
Documents
5
Period of Report
2025-12-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A g085027_def14a.htm DEF 14A 581980
2 GRAPHIC img001_v1.jpg GRAPHIC 36006
3 GRAPHIC img002_v1.jpg GRAPHIC 36006
4 GRAPHIC img003_v1.jpg GRAPHIC 223470
5 GRAPHIC img004_v1.jpg GRAPHIC 306668
  Complete submission text file 0001753926-25-001827.txt   1413175
Mailing Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703
Business Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703 919-908-2422
Pelthos Therapeutics Inc. (Filer) CIK: 0001919246 (see all company filings)

EIN.: 863335449 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41964 | Film No.: 251515307
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)